Search
The generous support of West Australians through Channel 7’s Telethon Trust will help support vital child health research at The Kids Research Institute Australia in 2023.
New research highlights the long-term physical health problems faced by people who survive drug-resistant tuberculosis (TB) .
A pilot clinical study, led in Australia by a The Kids Research Institute Australia and Perth Children's Hospital researcher, has found an immunotherapy drug can dramatically increase survival rates for babies with a rare form of leukaemia, paving the way for a major international clinical trial.
A huge congratulations to The Kids Research Institute Australia founding researcher, Emeritus Professor Carol Bower, who has been recognised in the King’s Birthday Honours for her profound impact on child and public health over a 40-year career.
Congratulations to prominent consumer advocate Catherine Hughes and The Kids Research Institute Australia honorary researcher Dr Noula Gibson, who have been named finalists in Research Australia’s 2023 Health and Medical Research Awards.
Eight The Kids Research Institute Australia-led projects will benefit from the latest round of WA Child Research Fund (WACRF) grants, announced this week by Medical Research Minister Stephen Dawson.
Researchers from the Rio Tinto Children’s Diabetes Centre, a JDRF Global Centre of Excellence, have been awarded funding through the WA Child Research Fund (WACRF) to undertake research that aims to remove barriers and provide access to the most effective diabetes technologies for all children newly
Childcare centres have flocked to take up a new evidence-based policy to help ensure young children get more of the physical activity they need to be healthy and developmentally on track.
The Kids Research Institute Australia has welcomed today’s announcement by the Cook Government and Minderoo Foundation of a $34.6 million boost for the Early Years Partnership to achieve better outcomes for children.
A promising new treatment pioneered in Western Australia for people with cystic fibrosis has commenced testing in a clinical trial in the United States and Australia.